Lactobacillus reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR Study

Previous studies have reported that probiotics may improve clinical and inflammatory parameters in patients with obesity and metabolic syndrome (MetS). Lactobacillus (L.) reuteri V3401 has shown promising results on the components of MetS in animal studies. We aimed to evaluate the effects of L. reu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenorio-Jiménez, Carmen, Martínez-Ramírez, María José, Del Castillo-Codes, Isabel, Arraiza-Irigoyen, Carmen, Tercero-Lozano, Mercedes, Camacho, José, Chueca, Natalia, García, Federico, Olza, Josune, Plaza-Díaz, Julio, Fontana, Luis, Olivares, Mónica, Gil, Ángel, Gómez-Llorente, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723328/
https://www.ncbi.nlm.nih.gov/pubmed/31370223
http://dx.doi.org/10.3390/nu11081761

Ejemplares similares

Ejemplares similares